{{chembox
| ImageFile = Bromisoval.svg
| ImageFile_Ref = {{chemboximage|correct|??}}
| ImageName = Skeletal formula of bromisoval
| IUPACName = (''RS'')-2-Bromo-''N''-carbamoyl-3-methylbutanamide{{citation needed|date=May 2012}}
|Section1={{Chembox Identifiers
| CASNo = 496-67-3
| CASNo_Ref = {{cascite|correct|??}}
| CASNo1 = 27109-49-5
| CASNo1_Ref = {{cascite|correct|??}}
| CASNo1_Comment = <small>''R''</small>
| PubChem = 2447
| PubChem1 = 146955
| PubChem1_Comment = <small>''R''</small>
| PubChem2 = 735997
| PubChem2_Comment = <small>''S''</small>
| ChemSpiderID = 2353
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID1 = 129594
| ChemSpiderID1_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID1_Comment = <small>''R''</small>
| ChemSpiderID2 = 643139
| ChemSpiderID2_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID2_Comment = <small>''S''</small>
| UNII = 469GW8R486
| UNII_Ref = {{fdacite|correct|FDA}}
| EINECS = 207-825-7
| KEGG = D01391
| MeSHName = Bromisovalum
| ChEBI = 31304
| ChEMBL = 1515611
| ChEMBL_Ref = {{ebicite|correct|EBI}}


| SMILES = CC(C)C(Br)c(:[o]):[nH]:c(:[nH2]):[o]
| SMILES1 = CC(C)C(Br)C(=O)NC(N)=O
| StdInChI = 1S/C6H11BrN2O2/c1-3(2)4(7)5(10)9-6(8)11/h3-4H,1-2H3,(H3,8,9,10,11)
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CMCCHHWTTBEZNM-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
}}
|Section2={{Chembox Properties
| C=6 | H=11 | Br=1 | N=2 | O=2
| LogP = 1.057
| pKa = 10.536
| pKb = 3.461
}}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = N05
| ATCCode_suffix = CM03
| AdminRoutes = Oral
}}
|Section8={{Chembox Related
| OtherFunction_label = ureas
| OtherFunction = [[Carbromal]]
| OtherCompounds = {{unbulleted list|[[3-Ureidopropionic acid]]|[[beta-Ureidoisobutyric acid|''beta''-Ureidoisobutyric acid]]|[[Carbamoyl aspartic acid]]|[[n-Acetylaspartic acid|''N''-Acetylaspartic acid]]|[[Aceglutamide]]|[[n-Acetylglutamic acid|''N''-Acetylglutamic acid]]|[[Citrulline]]}}
}}
}}

'''Bromisoval''' ([[International Nonproprietary Name|INN]]), commonly known as '''bromovalerylurea''', is a [[hypnotic]] and [[sedative]] of the [[bromoureide]] group discovered by Knoll in 1907 and patented in 1909.<ref>
{{ cite patent | country = US | status = patent | number = 914518 | gdate = 1909-03-09 | invent1 = Saam, E. | assign1 = Knoll | pridate = 1907-01-28 | title = Alpha-halogen-isovaleryl-urea and process of making the same
}}</ref>  It is marketed [[over-the-counter drug | over the counter]] in Asia under various trade names (such as ''Brovarin''<ref> {{ cite web | url = http://www.drugs.com/international/bromisoval.html | title = Bromisoval | work = International | publisher = Drugs.com }}</ref>), usually in combination with [[nonsteroidal anti-inflammatory drug]]s.

Chronic use of bromisoval has been associated with [[bromine]] poisoning.<ref>{{Cite journal 
| last1 = Hashida  | first1 = H. 
| last2 = Honda    | first2 = T. 
| last3 = Morimoto | first3 = H. 
| last4 = Aibara   | first4 = Y. 
| title = 市販鎮痛剤常用量の服用による慢性ブロム中毒の1例
| trans_title = A case of chronic bromvalerylurea intoxication due to habitual use of commercially available nonsteroidal anti-inflammatory drugs presenting an indefinite hyperchloremia 
| journal = Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 
| volume = 38 
| language = Japanese
| issue = 5 
| pages = 700–703 
| year = 2001 
| pmid = 11605223
| issn = 0300-9173
| doi = 10.3143/geriatrics.38.700 
| url = http://www.jstage.jst.go.jp/article/geriatrics1964/38/5/38_5_700/_pdf 
| format = pdf
}}</ref><ref>{{Cite journal 
| last1 = Kawakami  | first1 = T. 
| last2 = Takiyama  | first2 = Y. 
| last3 = Yanaka    | first3 = I. 
| last4 = Taguchi   | first4 = T. 
| last5 = Tanaka    | first5 = Y. 
| last6 = Nishizawa | first6 = M. 
| last7 = Nakano    | first7 = I. 
| title = Chronic bromvalerylurea intoxication: Dystonic posture and cerebellar ataxia due to nonsteroidal anti-inflammatory drug abuse 
| journal = Internal Medicine 
| location = Tokyo, Japan 
| volume = 37 
| issue = 9 
| pages = 788–791 
| year = 1998 
| pmid = 9804091 
| doi = 10.2169/internalmedicine.37.788
| url = http://www.jstage.jst.go.jp/article/internalmedicine1992/37/9/37_9_788/_pdf 
| format = pdf
}}</ref><ref>{{Cite journal 
| last1 = Wang | first1 = Y. -T. 
| last2 = Yang | first2 = S. Y. 
| last3 = Wu   | first3 = V. C. 
| last4 = Wu   | first4 = K. D. 
| last5 = Fang | first5 = C. C. 
| title = Pseudohyperchloraemia due to bromvalerylurea abuse 
| doi = 10.1093/ndt/gfh945 
| journal = Nephrology Dialysis Transplantation 
| volume = 20 
| issue = 8 
| pages = 1767–1768 
| year = 2005 
| pmid = 15972320 
| url = http://ndt.oxfordjournals.org/content/20/8/1767.2.full
| pmc = 
}}</ref><ref>{{Cite journal 
| last1 = Arai      | first1 = A. 
| last2 = Sato      | first2 = M. 
| last3 = Hozumi    | first3 = I. 
| last4 = Matsubara | first4 = N. 
| last5 = Tanaka    | first5 = K. 
| last6 = Soma      | first6 = Y. 
| last7 = Adachi    | first7 = T. 
| last8 = Tsuji     | first8 = S. 
| title = Cerebellar Ataxia and Peripheral Neuropathy due to Chronic Bromvalerylurea Poisoning 
| journal = Internal Medicine
| location = Tokyo, Japan 
| volume = 36 
| issue = 10 
| pages = 742–746 
| year = 1997 
| pmid = 9372340
| doi = 10.2169/internalmedicine.36.742
| url = http://www.jstage.jst.go.jp/article/internalmedicine1992/36/10/36_10_742/_pdf 
| format = pdf
}}</ref>

Bromovisal can be prepared by bromination of [[isovaleric acid]] by the [[Hell-Volhard-Zelinsky reaction]] followed by reaction with [[urea]].

==See also==
* [[Acecarbromal]]
* [[Carbromal]]
* [[Apronal]]

==References==
{{Reflist|2}}


{{Hypnotics}}
{{GABAAergics}}

[[Category:Hypnotics]]
[[Category:Sedatives]]
[[Category:Organobromides]]
[[Category:GABAA receptor positive allosteric modulators]]


{{sedative-stub}}